Cargando…
Nanotechnology-based products for cancer immunotherapy
ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555726/ https://www.ncbi.nlm.nih.gov/pubmed/34716502 http://dx.doi.org/10.1007/s11033-021-06876-y |
_version_ | 1784592035314925568 |
---|---|
author | Shams, Forough Golchin, Ali Azari, Arezo Mohammadi Amirabad, Leila Zarein, Fateme Khosravi, Atiyeh Ardeshirylajimi, Abdolreza |
author_facet | Shams, Forough Golchin, Ali Azari, Arezo Mohammadi Amirabad, Leila Zarein, Fateme Khosravi, Atiyeh Ardeshirylajimi, Abdolreza |
author_sort | Shams, Forough |
collection | PubMed |
description | ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a new branch of regenerative medicine-based therapies that uses engineering principles by using biological tools to stimulate the immune system. Therefore, this branch’s final aim is to regulate distribution, release, and simultaneous placement of several immune factors at the tumor site, so then upgrade the current treatment methods and subsequently improve the immune system’s handling. In this paper, recent research and prospects of nanotechnology-based cancer immunotherapy have been presented and discussed. Furthermore, different encouraging nanotechnology-based plans for targeting various innate and adaptive immune systems will also be discussed. Due to novel views in nanotechnology strategies, this field can address some biological obstacles, although studies are ongoing. GRAPHIC ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8555726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-85557262021-11-01 Nanotechnology-based products for cancer immunotherapy Shams, Forough Golchin, Ali Azari, Arezo Mohammadi Amirabad, Leila Zarein, Fateme Khosravi, Atiyeh Ardeshirylajimi, Abdolreza Mol Biol Rep Review ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a new branch of regenerative medicine-based therapies that uses engineering principles by using biological tools to stimulate the immune system. Therefore, this branch’s final aim is to regulate distribution, release, and simultaneous placement of several immune factors at the tumor site, so then upgrade the current treatment methods and subsequently improve the immune system’s handling. In this paper, recent research and prospects of nanotechnology-based cancer immunotherapy have been presented and discussed. Furthermore, different encouraging nanotechnology-based plans for targeting various innate and adaptive immune systems will also be discussed. Due to novel views in nanotechnology strategies, this field can address some biological obstacles, although studies are ongoing. GRAPHIC ABSTRACT: [Image: see text] Springer Netherlands 2021-10-29 2022 /pmc/articles/PMC8555726/ /pubmed/34716502 http://dx.doi.org/10.1007/s11033-021-06876-y Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Shams, Forough Golchin, Ali Azari, Arezo Mohammadi Amirabad, Leila Zarein, Fateme Khosravi, Atiyeh Ardeshirylajimi, Abdolreza Nanotechnology-based products for cancer immunotherapy |
title | Nanotechnology-based products for cancer immunotherapy |
title_full | Nanotechnology-based products for cancer immunotherapy |
title_fullStr | Nanotechnology-based products for cancer immunotherapy |
title_full_unstemmed | Nanotechnology-based products for cancer immunotherapy |
title_short | Nanotechnology-based products for cancer immunotherapy |
title_sort | nanotechnology-based products for cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555726/ https://www.ncbi.nlm.nih.gov/pubmed/34716502 http://dx.doi.org/10.1007/s11033-021-06876-y |
work_keys_str_mv | AT shamsforough nanotechnologybasedproductsforcancerimmunotherapy AT golchinali nanotechnologybasedproductsforcancerimmunotherapy AT azariarezo nanotechnologybasedproductsforcancerimmunotherapy AT mohammadiamirabadleila nanotechnologybasedproductsforcancerimmunotherapy AT zareinfateme nanotechnologybasedproductsforcancerimmunotherapy AT khosraviatiyeh nanotechnologybasedproductsforcancerimmunotherapy AT ardeshirylajimiabdolreza nanotechnologybasedproductsforcancerimmunotherapy |